Twenty-four hours after a cesarean birth a neonate, at 30 weeks' gestation, is diagnosed with respiratory distress syndrome (RDS). When explaining to the parents about the cause of this syndrome the nurse should include a discussion about altered secretion of:

Choice A rationale Testosterone is the primary male sex hormone, an androgen, responsible for the development of male secondary sex characteristics and reproductive tissues. While present in trace amounts in females, it has no direct role in the pulmonary physiology or the production of pulmonary surfactant, which is the critical deficiency leading to respiratory distress syndrome (RDS) in preterm neonates. Choice B rationale Somatotropin, also known as growth hormone (GH), is a peptide hormone responsible for stimulating growth, cell reproduction, and regeneration. Its main effects are on somatic growth and metabolism. Although many hormones influence fetal lung maturation indirectly, an altered secretion of somatotropin is not the primary physiological cause for the development of neonatal respiratory distress syndrome. Choice C rationale Surfactant is a lipoprotein complex produced by Type II alveolar cells. Its function is to lower the surface tension within the alveoli, preventing their collapse upon expiration. In preterm infants, especially those born before 34 weeks' gestation, the production of adequate amounts of surfactant is often immature or insufficient, leading to widespread atelectasis and the clinical picture of respiratory distress syndrome. Choice D rationale Progesterone is a major female sex hormone primarily involved in the menstrual cycle, pregnancy, and embryogenesis. It plays a crucial role in maintaining pregnancy by supporting the uterine lining. While steroid hormones are generally involved in fetal development, altered secretion of progesterone is not the main physiological factor causing the acute alveolar collapse seen in respiratory distress syndrome.